Mandate

Vinge Advises Active Biotech on Public Acquisition

April 18, 2008

The biotechnical company Active Biotech, listed on OMX Nordic Exchange in Stockholm will carry out a new share issue valued at SEK 160 million with preferential rights for its shareholders.

Active Biotech is represented by Erik Sjöman joined by Christian Lindhé.  

Related

Vinge advises EQT in connection with the sale of Eton

Vinge has advised EQT VII in connection with its sale of Eton to a consortium of private investors.
July 01, 2025

Vinge advises Triton in connection with the acquisition of Prenax

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.
July 01, 2025

Vinge advises Impilo on the establishment of Impilo Healthcare

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Healthcare. The fund will have EUR 320m in commitments.
July 01, 2025